Search company, investor...
Favor company logo


Founded Year



Series B - III | Alive

Total Raised


Last Raised

$41.9M | 2 yrs ago

About Favor

Favor provides an online birth control prescription and delivery service to simplify access to birth control. It delivers birth control, emergency contraception, and complimentary gifts while offering a personalized and connected healthcare experience. It ensures accessibility and personal freedom while empowering women to take charge of their health and bodies. It was formerly known as The Pill Club. It was founded in 2014 and is based in San Mateo, California.

Headquarters Location

411 Borel Ave Suite 100

San Mateo, California, 94402,

United States


Favor's Product Videos

Product Demo.png

ESPs containing Favor

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare & Life Sciences / Digital Pharmacy Tech

The direct-to-consumer (D2C) prescription services — dermatology market offers a convenient and accessible way for individuals to access prescription medications and dermatological treatments directly from the comfort of their homes. These services utilize online platforms and telemedicine to connect patients with licensed dermatologists who can diagnose conditions, prescribe medications, and prov…

Favor named as Highflier among 6 other companies, including Ro, Skin + Me, and Curology.

Compete with Favor?

Ensure that your company and products are accurately represented on our platform.

Favor's Products & Differentiators

    Contraception (Pill & Ring)

    120+ FDA approved birth control pill / ring options that are delivered to patients' doors in discrete packaging.

Research containing Favor

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Favor in 4 CB Insights research briefs, most recently on Sep 28, 2022.

Expert Collections containing Favor

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Favor is included in 7 Expert Collections, including E-Commerce.



10,711 items


Women's Health & Wellness

1,493 items

Startups focused on providing products and services catering to women's health and wellbeing.


Pharma Supply Chain

1,359 items


Digital Health 150

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Digital Health

10,348 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.



2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Favor Patents

Favor has filed 2 patents.

patents chart

Application Date

Grant Date


Related Topics





Application Date


Grant Date



Related Topics



Latest Favor News

TPCO : The Parent Company Reminds Shareholders to Vote in Favor of the Proposed Business Combination with Gold Flora and Provides Additional Disclosure - Form 8-K

Jun 6, 2023

06/06/2023 | 06:04am EDT Message : *Required fields The Parent Company Reminds Shareholders to Vote in Favor of the Proposed Business Combination with Gold Flora and Provides Additional Disclosure Meeting to be Held Thursday, June 15, 2023 at 12:00 PM ET | 9:00 AM PT SAN JOSE, Calif., June 6, 2023 - TPCO Holding Corp. ("The Parent Company" or the "Company") (NEO: GRAM) (OTCQX: GRAMF), a leading consumer-focused California cannabis company, today reminds shareholders that it will host its annual general and special meeting (the "Meeting") of the holders ("TPCO Shareholders") of common shares ("TPCO Shares") of the Company at 12:00 PM ET | 9:00AM PT on Thursday, June 15, 2023 via live audio webcast online. The purpose of the meeting will be for TPCO Shareholders to consider a special resolution to approve the previously announced proposed business combination (the "Business Combination") with Gold Flora, as well as other matters detailed in the Company's Definitive Circular filed on May 15, 2023 (the "Definitive Circular"), with the U.S. Securities and Exchange Commission (the "SEC"). The Company encourages TPCO Shareholders to carefully read the entire Definitive Circular (including any supplements to the Definitive Circular) as it contains a full description of the Business Combination, including the anticipated benefits of the combination. The Definitive Circular, as well as other relevant filings containing information about the Company and the Business Combination, can be accessed by going to the Company's Investor Relations page on its website at . How to Vote If you are a Registered TPCO Shareholder, your vote by proxy must be received before 11:59 pm (New York City time) on June 14, 2023, or, if the Meeting is adjourned or postponed, at least 48 hours (excluding Saturdays, Sundays and statutory holidays in the Province of British Columbia) before the beginning of any adjourned or postponed meeting. If you are a Non-Registered TPCO Shareholder (for example, if you hold TPCO Shares in an account with an intermediary), you should follow the voting procedures described in the form of proxy or voting instruction form provided by your intermediary or call your intermediary for information as to how you can vote your TPCO Shares. Note that the deadlines set by your intermediary for submitting your form of proxy or voting instruction form may be earlier than the dates described above. Your vote is important. If you have any questions regarding the terms of the Proxy Solicitation or requests for assistance relating to the procedures for delivering instructions, please contact Kingsdale Advisors, the Information Agent and Solicitation Agent, at 1-866-228-8614 or 647-251-9706 or by email at Annual General and Special Meeting Details: DATE: 1 Supplemental Disclosure Additionally, the Company announced today that it has filed with the SEC a Current Report on Form 8-K (the "Current Report") containing certain amended and supplemental disclosures that are intended to amend and supplement the Definitive Circular, without admitting in any way that such disclosures are material or otherwise required by law. The Current Report and supplemental disclosures are available on the SEC's website at and on SEDAR at and may also be found on the Investor Relations page of the Company's website at . The board of directors of the Company continues to unanimously (with interested directors recusing themselves from voting) recommend that TPCO Shareholders vote FOR the approval of the Business Combination. About The Parent Company The Parent Company is a leading consumer-focused, vertically integrated cannabis company with twelve retail locations, one delivery hub and a curated product portfolio, including Monogram by Shawn "JAY-Z" Carter, Caliva, Mirayo by Santana and Cruisers. The Parent Company is committed to leveraging its status to help build a more equitable cannabis industry. Its social equity venture fund aims to eliminate systematic barriers to entry and provide minority entrepreneurs with meaningful participation, growth, and leadership opportunities in the multibillion-dollar legal cannabis industry. The Parent Company common shares are traded on NEO Exchange under the ticker symbol "GRAM" and on the OTCQX under the ticker symbol "GRAMF." For the latest news, activities, and media coverage, please visit or connect with us on Instagram, LinkedIn, and Twitter. References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release. Additional Information and Where to Find It In connection with the Business Combination, on May 15, 2023, The Parent Company filed the Definitive Circular with the SEC. Additionally, The Parent Company and Gold Flora will file other relevant materials in connection with the proposed Business Combination with applicable securities regulatory authorities. Investors and security holders of The Parent Company are urged to carefully read the entire Definitive Circular (including any supplements to the Definitive Circular) before making any voting decision with respect to the Business Combination and the other matters described in the Definitive Circular because the Definitive Circular will contain important information about the proposed Business Combination and the parties to the Business Combination as well as the other matters described in the Definitive Circular. Investors and security holders of the Company will also be able to obtain a free copy of the Definitive Circular, as well as other relevant filings containing information about the Company and the Business Combination, without charge, at the website of the SEC at and on the Company's SEDAR profile, or from the Company by going to the Company's Investor Relations page on its website at . 2 Caution Regarding Cannabis Operations in the United States Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute, or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable U.S. federal money laundering legislation. While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve The Parent Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. The enforcement of federal laws in the United States is a significant risk to the business of The Parent Company and any proceedings brought against the Company thereunder may adversely affect the Company's operations and financial performance. Investor Contact:

Favor Frequently Asked Questions (FAQ)

  • When was Favor founded?

    Favor was founded in 2014.

  • Where is Favor's headquarters?

    Favor's headquarters is located at 411 Borel Ave, San Mateo.

  • What is Favor's latest funding round?

    Favor's latest funding round is Series B - III.

  • How much did Favor raise?

    Favor raised a total of $118.49M.

  • Who are the investors of Favor?

    Investors of Favor include Shasta Ventures, Base10 Partners, VMG Partners, Google Ventures, ACME Capital and 7 more.

  • Who are Favor's competitors?

    Competitors of Favor include Simple Health and 8 more.

  • What products does Favor offer?

    Favor's products include Contraception (Pill & Ring) and 3 more.

Compare Favor to Competitors

Ro Logo

Ro is a patient-driven telehealth company. Its network of physicians and pharmacies provides a personalized healthcare experience from online treatment to the delivery of medication and ongoing care. It was formerly known as Roman. It was founded in 2017 and is based in New York, New York.


ASYSTEM creates betterment products to help men look, feel, and perform at their best. Spanning supplements, vitamins, and personal care, its products combine science with nature. The company was founded in 2018 and is based in Venice, California.


Numan offers an online platform that aims to promote accessible medical remedies for erectile dysfunction. The company seeks to build a brand around health issues affecting men's self-esteem and the lifestyle choices they make that might affect their condition.

Pandia Health Logo
Pandia Health

Pandia Health provides a one-stop shop for recurring medications, starting with birth control. Pandia Health offers free and discreet delivery of the pill, patch, or ring as well as emergency contraceptives.


Manual is an online retailer of sex and hair products for men.

Twentyeight Health Logo
Twentyeight Health

Twentyeight Health offers a women's health platform. It focuses on increasing reproductive and sexual health care access to underserved communities. It provides online doctor consultations for prescriptions and birth control products home delivered. The company was founded in 2018 and is based in Brooklyn, New York.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.